<DOC>
	<DOCNO>NCT02854371</DOCNO>
	<brief_summary>Liver function key factor help predict clinical outcome patient cirrhosis . Traditionally , liver function measure use either indocyanine green ( ICG ) radionucleotides . Recently , gadoxetic acid report show liver function several study . There several approach measure liver function use gadoxetic acid , hepatocyte fraction one promising method . Since gadoxetic acid enhance liver MRI clinically use world widely , would valuable measure liver function use hepatocyte fraction .</brief_summary>
	<brief_title>Evaluation Hepatic Function Using Gadoxetic Acid Enhanced MRI</brief_title>
	<detailed_description />
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>patient chronic liver disease liver cirrhosis clinically schedule gadoxetic acid enhance liver MRI sign informed consent 18 year transarterial chemoembolization , radiation therapy liver bile duct within 2 week systemic chemotherapy within 6 week contraindication contrast enhance MRI hepatic iron deposition prior image bile duct obstruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>gadoxetic acid</keyword>
	<keyword>T1 map</keyword>
	<keyword>MRI</keyword>
</DOC>